CN1453264A - Prepn of cis-N-methyl-4-(3,4-dichlorophenyl)-1, 2, 3, 4-tetrahydro-1-naphthylamine and its derivative - Google Patents
Prepn of cis-N-methyl-4-(3,4-dichlorophenyl)-1, 2, 3, 4-tetrahydro-1-naphthylamine and its derivative Download PDFInfo
- Publication number
- CN1453264A CN1453264A CN 02117189 CN02117189A CN1453264A CN 1453264 A CN1453264 A CN 1453264A CN 02117189 CN02117189 CN 02117189 CN 02117189 A CN02117189 A CN 02117189A CN 1453264 A CN1453264 A CN 1453264A
- Authority
- CN
- China
- Prior art keywords
- methyl
- cis
- general formula
- tetrahydrochysene
- naphthalidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention discloses the one-step reaction process of preparing cis-N-methyl-4-(dichloro, phenyl)-1, 2, 3, 4-tetrahydro-1-naphthylamine and its derivative by using 4-(substituted phenyl)-3, 4-dihydro-naphthyl-1-ketone and its derivative as material. The said process has easy operation and high yield, and is one new method of synthesizing intermediate for Sertraline hydrochloride.
Description
Invention field
The present invention relates to prepare the method for following compound:
The invention discloses with 4-(substituted-phenyl)-3,4-dihydro-naphthalene-1-ketone and derivative thereof are raw material, obtain N-methyl-4-(substituted-phenyl)-1,2,3, the method for 4-tetrahydrochysene-naphthalidine and derivative thereof, wherein R through single step reaction
1And R
2Be hydrogen, halogen or alkane substituting group, R
3Be hydrogen or alkane substituting group, R
4Be alkyl substituent.This compound can be used for preparing sertraline hydrochloride and derivative thereof.
Background of invention
U.S. Pat 4536518 and Journal of Medicinal Chemistry, 1984, vol27, all reported among the 1508-1515 with 4-(substituted-phenyl)-3,4-dihydro-naphthalene-1-ketone is raw material, with the titanium tetrachloride is catalyzer, generate N-methyl-4-(substituted-phenyl)-1,2,3 with the methylamine effect, 4-tetrahydrochysene-1-naphthalene imines, this imines obtains N-methyl-4-(substituted-phenyl)-1,2,3 through sodium borohydride or catalytic hydrogenation reduction, 4-tetrahydrochysene-naphthalidine, this method products therefrom cis-trans ratio is 7: 3.
These existing technology all do not relate to or advise of the present inventionly with 4-(substituted-phenyl)-3, and 4-dihydro-naphthalene-1-ketone is raw material, obtains N-methyl-4-(substituted-phenyl)-1,2,3, the method for 4-tetrahydrochysene-naphthalidine through single step reaction.
Goal of the invention
The purpose of this invention is to provide a kind of easy preparation sertraline hydrochloride and the key intermediate N-methyl-4-(substituted-phenyl)-1,2,3 of derivative thereof, the method for 4-tetrahydrochysene-naphthalidine.
Summary of the invention
The invention provides a kind of new preparation method of following compound:
Flow process is as follows:
R wherein
1And R
2Be hydrogen, halogen or alkane substituting group, R
3Be hydrogen or alkane substituting group, R
4Be alkyl substituent.
Content of the present invention has following advantage:
1. do not need to use titanium tetrachloride in this law, avoided because of the operation of adopting titanium tetrachloride to bring problems such as loaded down with trivial details and environmental pollution; Solvent for use needn't make simplified control through no water treatment simultaneously.
2. this law only needs single step reaction, and solvent for use and palladium catalyst carbon are all recyclable to be applied mechanically, and aftertreatment is simple, is easier to suitability for industrialized production.
3. present method stereoselectivity is strong, the product cis-isomeride ratio of gained can reach more than 90%, and U.S. Pat 4536518 and Journal of Medicinal Chemistry, 1984, vol 27, method cis-isomeride ratio described in the 1508-1515 is 70%, make to adopt this law prepare that the hydrochloric acid house is got woods and the derivative yield is higher.
Embodiment
Embodiment 1
1L hydrogenation reaction steel cylinder adds 200 milliliters of methylamine alcohol solutions, 200 milliliters of anhydrous methanols, and 4-(3, the 4-dichlorophenyl)-3, (20g 0.074mol), stirs palladium carbon 1 gram of adding 10% down to 4-dihydro-naphthalene-1-ketone, feeds hydrogen, catalytic hydrogenation under the room temperature.To the disappearance of thin layer point plate analysis raw material point, stopped reaction.Elimination palladium carbon, the filtrate decompression solvent evaporated, the off-white color solid, be N-methyl-4-(substituted-phenyl)-1,2,3,4-tetrahydrochysene-naphthalidine, claim 19.8 the gram, yield 93.8%.The proton nmr spectra data are as follows:
1H-NMR (300MHz, DMSO-d
6) δ: 1.97-2.13 (4H, m ,-CH
2-CH
2-), 2.63 (3H, s ,-CH
3), 4.10 (1H, t ,-CH-), 4.33 (1H, t ,-CH-), 6.73 (1H, d ,-Ar), 7.24-7.35 (4H, m ,-Ar), 7.49-7.53 (2H, m ,-Ar).
Embodiment 2
To purify with column chromatography by example 1 operation gained off-white color solid, sorbent material is a 300-400 order silica gel, and eluent is a sherwood oil: ethyl acetate: triethylamine=40: 20: 1.Going out component earlier is cis-isomeride, and gained cis and trans-isomer(ide) are collected respectively, weighs, and calculating the two weight ratio is cis: trans=9: 1.
Embodiment 3
To add isopropyl ether by example 1 operation gained white solid, and stir and feed hydrogen chloride gas down, to pH value be about 2, stop ventilation, stirring half an hour.Suction filtration, filter cake adds the 200ml anhydrous methanol, is heated to dissolving.Cooling adds the 150ml tetrahydrofuran (THF), and refrigerator and cooled is frozen and spent the night, white solid.The gained solid is separated salt, get light yellow oil 15.6 grams.Method by example 2 is collected cis and trans-isomer(ide) respectively, and calculating the cis-isomeride proportion is about 97%.
Embodiment 4
As expect cis N-methyl-4-(substituted-phenyl)-1,2,3 that ratio is higher, 4-tetrahydrochysene-naphthalidine can repeat the operation of example 3.
Claims (5)
This method comprises:
With general formula (2) and alkylamine alcoholic solution is raw material, is catalyzer with palladium carbon, carries out hydrogenation reaction, and temperature range is 10 ℃-80 ℃, and pressure range is a 1-50 normal atmosphere, through single step reaction, obtains general formula (1) compounds.
General formula (2)
R in general formula (1) and the general formula (2)
1And R
2Be hydrogen, halogen or alkane substituting group, R
3Be hydrogen or alkane substituting group.
2. the process of claim 1 wherein that used alkylamine alcoholic solution is a methylamine alcohol solution, commercially available or self-control, concentration is 10%-30%.
3. the method for claim 1 can add anhydrous methanol (or dehydrated alcohol) and make solvent, increases reactant solubility, improves the mixing effect in the reaction process, and wherein anhydrous methanol (or dehydrated alcohol) is 0-10 with the volume ratio scope of methylamine alcohol solution.
4. the method for claim 1, can obtain along reverse proportionality is N-methyl-4-(substituted-phenyl)-1,2 of 9: 1,3,4-tetrahydrochysene-naphthalidine, product can separate cis and trans-isomer(ide) by column chromatography method, obtain purified cis N-methyl-4-(3, the 4-dichlorophenyl)-1,2,3,4-tetrahydrochysene-naphthalidine, and then obtain (the 4S)-N-methyl-4-(3 of cis-(1S) by fractionation, the 4-dichlorophenyl)-1,2,3,4-tetrahydrochysene-naphthalidine (Sertraline).
5. the method for claim 1, products therefrom also can obtain purified cis N-methyl-4-(3, the 4-dichlorophenyl)-1,2 by the method for recrystallization behind the salify, 3,4-tetrahydrochysene-naphthalidine, and then obtain (the 4S)-N-methyl-4-(3, the 4-dichlorophenyl)-1 of cis-(1S) by fractionation, 2,3,4-tetrahydrochysene-naphthalidine (Sertraline), the solvent of recrystallization are the mixed solvent of methyl alcohol and tetrahydrofuran (THF).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02117189 CN1453264A (en) | 2002-04-25 | 2002-04-25 | Prepn of cis-N-methyl-4-(3,4-dichlorophenyl)-1, 2, 3, 4-tetrahydro-1-naphthylamine and its derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02117189 CN1453264A (en) | 2002-04-25 | 2002-04-25 | Prepn of cis-N-methyl-4-(3,4-dichlorophenyl)-1, 2, 3, 4-tetrahydro-1-naphthylamine and its derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1453264A true CN1453264A (en) | 2003-11-05 |
Family
ID=29257210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02117189 Pending CN1453264A (en) | 2002-04-25 | 2002-04-25 | Prepn of cis-N-methyl-4-(3,4-dichlorophenyl)-1, 2, 3, 4-tetrahydro-1-naphthylamine and its derivative |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1453264A (en) |
-
2002
- 2002-04-25 CN CN 02117189 patent/CN1453264A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103664677A (en) | Asymmetric synthesis method of (R,R)-formoterol tartrate | |
JPH03176459A (en) | Preparation of 1-(aminomethyl) cyclohexaneacetic acid | |
JP2580736B2 (en) | Optically active hydroxybenzylamine derivative, intermediate thereof and method for producing the same | |
CN110156645A (en) | A kind of preparation method of florfenicol midbody | |
CN112174842B (en) | Method for preparing (S) -3-amino-2-benzyl propionic acid | |
CN1453264A (en) | Prepn of cis-N-methyl-4-(3,4-dichlorophenyl)-1, 2, 3, 4-tetrahydro-1-naphthylamine and its derivative | |
CN112961030B (en) | Method for catalytic synthesis of 4- (trans-4-alkyl cyclohexyl) cyclohexanone | |
CN117486730B (en) | Dicyclohexyl group Process for the preparation of methylamines | |
CN115945215B (en) | Sodium lignin sulfonate quaternary ammonium salt supported phosphotungstic acid catalyst, preparation method thereof and application of oxidized oleic acid in preparation of azelaic acid | |
CN100364966C (en) | Process of synthesizing 1-[2-amino-1-(p-methoxylphenyl)-ethyl] cyclohexanol formate | |
JPS62185032A (en) | Production of 1-(1-hydroxyethyl)-alkylcyclohexane | |
CA2496847C (en) | Process for producing aminobenzopyran compound | |
CN114605241B (en) | Preparation method of esketamine hydrochloride intermediate and intermediate thereof | |
CN112194589B (en) | Synthesis method of 2, 6-dichloro-4- ((4-hydroxyphenyl) amino) phenol | |
CN111518088B (en) | Preparation method and application of aniline quinazoline intermediate | |
CN112441935B (en) | Synthesis method of beta-aminoketone compound | |
CN111187175A (en) | Method for preparing intermediate of brivaracetam by hydrogenation of microchannel reactor | |
CN102120726A (en) | New preparation method of (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrobenzene)-N,N-diethyl-2-acrylamide | |
EP0663394B1 (en) | Process for preparing 5-aminodihydropyrrole, intermediate thereof and process for preparing said intermediate | |
CN113372323A (en) | Method for synthesizing camptothecin compound intermediate under microwave and normal pressure | |
CN116003305A (en) | Preparation method of 5-ethyl-2-pyrrole carboxylic acid | |
JPH0853394A (en) | Production of phenyllactic acid derivative | |
JP4366854B2 (en) | 12-amino-4,8-dodecadienenitrile and process for producing the same | |
CN117417232A (en) | Synthesis method of alcohol compound | |
CN112707924A (en) | Synthetic method of 4-aminomethyl phenylboronic acid hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |